References
- E. Barbu, I. Sarvaiya, K. L. Green, T. G. Nevell and J. Tsibouklis, Vinylpyrrolidone-co-(meth) acrylic acid inserts for ocular drug delivery: synthesis and evaluation, J. Biomed. Mater. Res. 74 (2005) 598-606; DOI: 10.1002/jbm.a.30329.
- N. Gangopadhyay, M. Daniell, L. Weih and H. Taylor, Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers, Br. J. Ophthalmol. 84 (2000) 378-384; DOI: 10.1136/bjo.84.4.378.
- A. P. Smith, M. Pennefather, S. B. Kaye and C. A. Hart, Fluoroquinolones: place in ocular therapy, Drugs 61 (2001) 747-761.
- P. E. Cutarelli, J. H. Lass, H. M. Lazarus, S. C. Putman and M. R. Jacobs, Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity, Curr. Eye Res. 10 (1991) 557-563; DOI: 10.3109/02713689109001764.
- P. L. Mallari, D. J. McCarty, M. Daniell and H. Taylor, Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis, Am. J. Ophthalmol. 131 (2001) 131-133; DOI: 10.1016/S0002-9394(00)00642-5.
- S. Barath and S. R. Hiremath, Ocular delivery system of perfloxacin mesylate, Pharmazie 54 (1999) 55-58.
- A. S. Mundada and B. K. Srikhande, Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert, Curr. Eye Res. 33 (2008) 469-475; DOI: 10.1080/02713680802023104.
- G. Di Colo, S. Burgalassi, P. Chetoni, M. P. Fiaschi, Y. Zambito and M. F. Saettone, Gel-forming erodible inserts for ocular controlled delivery of ofloxacin, Int. J. Pharm. 14 (2001) 101-111; DOI: 10.1016/S0378-5173(02)00421-0.
- J. M. Woodcock, J. M. Andrews, F. J. Boswell, N. P. Brenwald and R. Wise, In vitro activity of BAY 12-8039, a new fluoroquinolone, Antimicrob. Agents Chemother. 41 (1997) 101-106.
- E. Pestova, J. J. Millichap, G. A. Noskin and L. R. Peterson, Intracellular targets of moxacifloxacin: a comparison with other fluoroquinolones, J. Antimicrob. Chemother. 45 (2000) 583-590; DOI: 10.1093/jac/45.5.583.
- P. K. Pawar and D. K. Majumdar, Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep and buffalo corneas, AAPS PharmSci Tech. 7 (2006) E13.
- P. K. Pawar and D. K. Majumdar, In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas, Pharmazie 62 (2007) 853-857; DOI: 10.1691/PH.2007.11.7055.
- M. Malhotra and D. K. Majumdar, In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops, Indian J. Exp. Biol. 35 (1997) 941-947.
- L. Perioli, V. Ambrogi, S. Giovagnoli, M. Ricci, P. Blasi and C. Rossi, Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen, AAPS PharmSciTech. 8 (2007) E54; DOI: 10.1208/pt0803054.
- P. Costa and L. J. Manuel Sousa, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.
- V. Shankar, A. K. Chandrasekaran, S. Durga, G. Geetha and V. A. Ravichandran, Design and evaluation of diclofenac sodium ophthalmic inserts, Acta Pharm. Sci. 48 (2006) 5-10.
- International Conference on Harmonization, Q1A (R2): Stability Testing of New Drug Substances and Products, ICH, Geneva 2003.